NiO
x
-promoted Cu-based catalysts derived
from CuNi phyllosilicates were synthesized, characterized, and tested
in the selective hydrogenation of adipic acid to 1,6-hexanediol. The
reduction of the CuNi phyllosilicate allows finely dispersed Cu0 and Cu+ on the surface. The reduced Cu36Ni5PS catalyst was found to have a higher turnover frequency
for the selective hydrogenation of adipic acid than the reduced Cu41PS, Cu40Ni1PS, and Cu31Ni10PS catalysts. This catalyst is also effective at hydrogenation
of succinic acid, glutaric acid, butyric acid, pentanoic acid, and
hexanoic acid to their respective alcohols. The higher activity of
the reduced Cu36Ni5PS catalyst is attributed
to a higher oxidation state of Cu cations.
A reduction–silylation–reduction
method was developed
to synthesize hydrophobic Cu catalysts derived from Cu phyllosilicates
(CuPS). Triethoxy(octyl)silane (OTS) was used as the coupling agent.
The OTS-grafted, reduced CuPS catalysts were applied in the hydrogenation
of levulinic acid (LA) to γ-valerolactone (GVL). The most promising
catalyst was synthesized by reducing CuPS at a high temperature (350
°C for 3 h), followed by OTS grafting, and then by repeating
the previous reduction step. High LA conversion (95.7%), GVL yield
(85.2%), and stability (3 cycles with a 7.5% loss of initial activity)
were obtained at a mild reaction condition (130 °C with a H2 pressure of 12 bar). A high reduction temperature not only
leads to a low oxidation state of Cu species but also suppresses the
formation of silylation-induced acids. Moreover, the intrinsic activity
of a reduced CuPS catalyst was nearly intact after subjecting to silylation
and the second reduction treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.